Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1999-5-4
|
pubmed:abstractText |
The diagnostic criteria for RBD requires the presence of at least five out of nine depressive symptoms analogous to the symptoms of major depression, yet a duration of less than two weeks, a recurrence of at least 12 times a year, and the evidence of impairment in occupational or other important areas of functioning. The lack of a successful treatment represents one of the main challenges of this disorder. The therapeutic value of lithium in RBD has been suggested by Montgomery, but the specific efficacy of this agent has not been tested yet in the case of patients with recurrent brief depressive disorder.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0006-3223
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
927-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9807652-Acute Disease,
pubmed-meshheading:9807652-Adult,
pubmed-meshheading:9807652-Antidepressive Agents,
pubmed-meshheading:9807652-Antidepressive Agents, Tricyclic,
pubmed-meshheading:9807652-Depression,
pubmed-meshheading:9807652-Drug Administration Schedule,
pubmed-meshheading:9807652-Drug Resistance,
pubmed-meshheading:9807652-Drug Therapy, Combination,
pubmed-meshheading:9807652-Humans,
pubmed-meshheading:9807652-Lithium,
pubmed-meshheading:9807652-Male,
pubmed-meshheading:9807652-Recurrence
|
pubmed:year |
1998
|
pubmed:articleTitle |
Recurrent brief depression successfully treated with lithium.
|
pubmed:affiliation |
Department of Psychiatry, Hospital General de Manresa, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article,
Case Reports
|